
KWF Kankerbestrijding
AI Verified
Netherlands
Venture Capital
Amsterdam, North Holland, Netherlands
1949
Criteria | Requirements | Match |
---|---|---|
Regions | Western Europe |
00
|
Countries |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Sector |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Impact Area |
00 00 00
|
|
Stage | Pre-Seed, Seed, Series A, Growth Stage |
00
|
Ticket size |
00 00 00
-
00 00 00
USD
|
00
|
Monetization model |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Product readiness |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Client types |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Min. revenue |
00 00 00
USD
|
00
|
Other |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
- |
Company description
KWF Kankerbestrijding has been making a significant impact in the fight against cancer in the Netherlands for over seven decades. With cancer affecting virtually every Dutch citizen either directly or indirectly through loved ones, KWF works tirelessly to address the overwhelming consequences of this disease. Their comprehensive approach combines cutting-edge research funding with practical support systems, creating a multi-faceted strategy that has been helping millions of lives daily since their founding in 1949. Their mission extends beyond merely combating cancer to improving quality of life for those affected by it.
As the Netherlands' premier cancer charity, KWF has established itself as a pivotal force in oncology research investment. The organization strategically allocates resources to promising scientific investigations that have potential for breakthrough treatments. A key focus area involves accelerating access to innovative medications, ensuring that effective but expensive treatments become available to all patients regardless of socioeconomic status. Their investment portfolio spans from fundamental research to clinical applications, with particular emphasis on projects that can translate to practical patient benefits in the near term.
Beyond financial support for research, KWF has developed an extensive support infrastructure for cancer patients and their families. Their network includes welcoming community centers that provide face-to-face assistance and the digital platform kanker.nl, which serves as a safe online community where those affected by cancer can find information, share experiences, and receive guidance. This comprehensive ecosystem of support addresses not only medical concerns but also psychological, social, and practical challenges faced by patients throughout their cancer journey, from diagnosis through treatment and into survivorship or end-of-life care.
KWF's vision encompasses three core objectives: reducing cancer incidence through prevention initiatives, improving cure rates through research and treatment accessibility, and enhancing quality of life for those living with and beyond cancer. To achieve these goals, they actively mobilize nationwide participation through awareness campaigns, fundraising events, and volunteer programs that engage citizens across the Netherlands. Their tagline "Against cancer. For life." encapsulates their dual commitment to fighting the disease while affirming the value of each life affected by it, reflecting their understanding that the ultimate purpose of their work is to preserve what makes life meaningful for everyone touched by cancer.
Highlights
Ready to raise better?
Create your Free Account!
Frequently asked questions
KWF Kankerbestrijding maintains its global headquarters in Netherlands, serving as the strategic center for its operations. The company's primary corporate offices are located at Amsterdam, North Holland, Netherlands.
KWF Kankerbestrijding focuses its investment activities on companies operating in the following stages: Pre-Seed, Seed, Series A, Growth Stage. KWF Kankerbestrijding provides strategic capital and expertise to support promising businesses at these critical phases of development.
KWF Kankerbestrijding maintains a strategic global investment presence, actively seeking opportunities across the following key regions: Western Europe.
KWF Kankerbestrijding was established in 1949, marking the beginning of its journey as an investment firm.
KWF Kankerbestrijding is the following type of investment firm: Venture Capital. The organization provides capital and strategic support to entrepreneurs and growing companies.